British journal of haematologyHumansWaldenstrom MacroglobulinemiaProto-Oncogene Proteins c-bcl-2Antineoplastic AgentsLymphoma
BCL-2 inhibition in Waldenström macroglobulinaemia and marginal zone lymphoma.
Shayna Sarosiek, Uriel Suarez, Maria Fernandez-Turizo, Kristopher A Sarosiek, Jorge J Castillo
Published: 202510.1111/bjh.70208
Abstract
Marginal zone lymphoma (MZL) and Waldenström macroglobulinaemia (WM) are B-cell lymphomas characterized by an indolent disease course. However, both are incurable with current standard treatments. Therefore, additional therapies are certainly needed.…
Preview only. Read the full abstract at the source